Premaitha Health PLC Holding(s) in Company (6794K)
September 23 2016 - 5:42AM
UK Regulatory
TIDMNIPT
RNS Number : 6794K
Premaitha Health PLC
23 September 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Premaitha Health plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
---------------------------------------------------------- ---------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
------------------------------------------------------------- ------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------- ------------------------------
An acquisition or disposal of instruments with ü
similar economic effect to qualifying financial
instruments
------------------------------------------------------------- ------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------- ------------------------------
Other (please
specify):
---------------------------------------------------- ------- ------------------------------
3. Full name of person(s) Life Technologies Limited,
subject to the a company incorporated in
notification obligation: Scotland with company number
(iii) SC083107
------------------------------------------------------ -------------------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
------------------------------------------------------ -------------------------------------
5. Date of the transaction 22 September 2016
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------ -------------------------------------
6. Date on which issuer 23 September 2016
notified:
------------------------------------------------------ -------------------------------------
7. Threshold(s) that is/are Below 9% and through 9%, 10%,
crossed or 11%, 12% and 13%
reached: (vi, vii)
------------------------------------------------------ -------------------------------------
8. Notified details:
------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- ------------------------ -------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- ---------- ------------ ------------- --------------------- -----------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- --------- ------------ ------------- -------- ----------- ------------ ---------
B: Qualifying Financial Instruments
------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date (xiii) Conversion rights that rights
instrument Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
-------------- ----------------------- ------------- --------------------- -----------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
-------------- --------- ------------ ------------- --------------------- -----------------------
Warrants 24.6p 11 December Exercisable Nominal Delta
2023 up to
11 December
2023
-------------- --------- ------------ ------------- ------------ ---------
8.9%
(based
on current
share
capital)
and
7.07%
(based
on
so-enlarged
share
20,325,204 capital)
------------- --------- ------------ ------------- --------------------- ------------ ---------
Nominal
7.5%
(based
on current
share
capital)
and
5.95%
(based
Exercisable on
up to so-enlarged
11 December 11 December share
Warrants 11.7p 2023 2023 17,094,018 capital) Delta
-------------- --------- ------------ ------------- --------------------- ------------ ---------
Total (A+B+C)
------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
--------------------------------------- -------------------------------------------------------------
37,419,222 16.4% (based on current share
capital) and 13.03% (based
on so-enlarged share capital).
--------------------------------------- -------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
----------------------------------------------------------------------------------
Life Technologies Limited is a controlled undertaking
of Thermo Fisher Scientific Inc. a company incorporated
in the United States of America.
Proxy Voting:
----------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- -------------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- -------------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- -------------------
13. Additional information:
------------------------------------------------------------- -------------------
14. Contact name: Ted Fong
------------------------------------------------------------- -------------------
15. Contact telephone number: 001 (650) 244-1616
------------------------------------------------------------- -------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUOSKRNRAKURR
(END) Dow Jones Newswires
September 23, 2016 05:42 ET (09:42 GMT)
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Apr 2023 to Apr 2024
